Inspite of attaining a whole reaction with exceptional induction therapy, minimal residual sickness normally persists, necessitating consolidation therapy to mitigate the risk of relapse by doing away with residual condition. In people who definitely have gained seven+3 induction therapy, consolidation therapy is initiated with large-dose cytarabi